Page last updated: 2024-10-20

pyrazinamide and Diabetic Nephropathies

pyrazinamide has been researched along with Diabetic Nephropathies in 2 studies

pyrazinecarboxamide : A monocarboxylic acid amide resulting from the formal condensation of the carboxy group of pyrazinoic acid (pyrazine-2-carboxylic acid) with ammonia. A prodrug for pyrazinoic acid, pyrazinecarboxamide is used as part of multidrug regimens for the treatment of tuberculosis.

Diabetic Nephropathies: KIDNEY injuries associated with diabetes mellitus and affecting KIDNEY GLOMERULUS; ARTERIOLES; KIDNEY TUBULES; and the interstitium. Clinical signs include persistent PROTEINURIA, from microalbuminuria progressing to ALBUMINURIA of greater than 300 mg/24 h, leading to reduced GLOMERULAR FILTRATION RATE and END-STAGE RENAL DISEASE.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kriki, P1
Thodis, E1
Deftereos, S1
Panagoutsos, S1
Theodoridis, M1
Kantartzi, K1
Mourvati, E1
Prassopoulos, P1
Passadakis, P1
Vargemezis, V1
Shichiri, M1
Iwamoto, H1
Shiigai, T1

Other Studies

2 other studies available for pyrazinamide and Diabetic Nephropathies

ArticleYear
A tumor-like manifestation of extrapulmonary tuberculosis in a hemodialysis patient.
    Clinical nephrology, 2009, Volume: 71, Issue:6

    Topics: Diabetic Nephropathies; Diagnosis, Differential; Drug Therapy, Combination; Ethambutol; Humans; Ison

2009
Diabetic renal hypouricemia.
    Archives of internal medicine, 1987, Volume: 147, Issue:2

    Topics: Adult; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans; Kidney Tubules; Male; Midd

1987